The Valens Company and Verse Cannabis Roll Out Products at Medical Cannabis by Shoppers Inc.

Select products from the Verse Originals and Verse Concentrates lines will be available in the coming weeks across Canada through the national medical cannabis retail platform

KELOWNA, BC, March 17, 2021 /PRNewswire/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a leading manufacturer of cannabis products, today announced that it will be distributing select products from its partner Verse Cannabis (“Verse”) to the Medical Cannabis by Shoppers™ platform. Products have been selected from each Verse Cannabis line, Verse Originals and Verse Concentrates, which are custom manufactured by Valens and aim to bring premium quality offerings to Canadian consumers at affordable prices.

From the Verse Concentrates line, Medical Cannabis by Shoppers will feature Verse Crumble, derived from an indica-dominant White Rhino strain, with pinene, myrcene, and caryophyllene terpenes that create a fruity and piney aroma. Extracted with Valens’ proprietary hydrocarbon method, the 1g product features a broad spectrum of cannabinoids and has a honeycomb-like consistency. At approximately 75-80 percent THC, this crumble was created for an experienced consumer and comes in a non-reactive glass container to preserve freshness. It is the first crumble product and one of few concentrate products available in the Medical Cannabis by Shoppers platform.

Medical Cannabis by Shoppers will also offer vape cartridges in a variety of flavours and terpene-rich blends from the popular Verse Originals line, including:

  • Tropic Lemon, a top-selling, sativa-dominant blend inspired by Lemon Jack and Tropic Thunder cultivars.
  • Summer Berry, an indica-dominant blend inspired by Blue Zkittles and Watermelon OG cultivars.
  • Mandarin Mint, a sativa-dominant blend inspired by Tangie and Thin Mint GSC cultivars.
  • Sunset Peach, a sativa-dominant blend inspired by Peach Ozz and Strawberry Ice cultivars.

Since launching last year, Verse Cannabis’ products have stood out in the Canadian recreational market for their quality and price point despite only being available at select provincial retailers. Offering these popular products through a national cannabis retail platform like Medical Cannabis by Shoppers gives patients across the country increased accessibility to our partner’s differentiated product offerings.

Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company

We are pleased that Medical Cannabis by Shoppers is encouraged by the continued consumer demand we’ve seen for these products with other retailers, and this rollout demonstrates the strategic value that Valens strives to bring its partners through its far-reaching distribution network and manufacturing excellence.

In partnership, Valens and Verse expect to launch additional formats on the platform, including soft chews and pre-rolls, in the coming quarters.

About The Valens Company

The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The Valens Company’s high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation. Its breakthrough patented emulsification technology, SōRSE™ by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets. Through its wholly owned subsidiary Valens Labs Ltd., the Company is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company and its subsidiaries at

About Verse

Introducing Verse…

There is a clear need in the marketplace for Verse. On the one hand, beautifully branded and marketed flower-based brands line the shelves of cannabis stores nationwide. On the other hand, quality-obsessed craft products, fill the needs of those demanding more, but at a high price.

This is where the idea for Verse was born. An assortment of the highest quality cannabinoid-based Gen2 products accessible to all. A brand whose North Star would always be innovation and quality but values like realness and honesty would trump frills and gimmicks.

Like the verse of a song or poem, where creativity follows the rules of rhythm to become attractive to its listener, so does Verse, combining creative innovation with the rules of science to engineer extraordinary experiences for consumers.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter